{"id":"https://openalex.org/W4405259072","doi":"https://doi.org/10.22158/jepf.v10n4p365","title":"A Study of the Performance of Successive Mergers and Acquisitions of WuXi PharmaTech's Pharmaceutical and Biotechnology Companies","display_name":"A Study of the Performance of Successive Mergers and Acquisitions of WuXi PharmaTech's Pharmaceutical and Biotechnology Companies","publication_year":2024,"publication_date":"2024-12-11","ids":{"openalex":"https://openalex.org/W4405259072","doi":"https://doi.org/10.22158/jepf.v10n4p365"},"language":"en","primary_location":{"id":"doi:10.22158/jepf.v10n4p365","doi":"https://doi.org/10.22158/jepf.v10n4p365","is_oa":true,"landing_page_url":"https://doi.org/10.22158/jepf.v10n4p365","pdf_url":"http://www.scholink.org/ojs/index.php/jepf/article/download/55498/11153","source":{"id":"https://openalex.org/S4210220026","display_name":"Journal of Economics and Public Finance","issn_l":"2377-1038","issn":["2377-1038","2377-1046"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Economics and Public Finance","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.scholink.org/ojs/index.php/jepf/article/download/55498/11153","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108575570","display_name":"Qingzheng Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I41208885","display_name":"Harbin University of Commerce","ror":"https://ror.org/03zsxkw25","country_code":"CN","type":"education","lineage":["https://openalex.org/I41208885"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Qingzheng Chen","raw_affiliation_strings":["Harbin University of Commerce , Harbin , Heilongjiang , 150006 , China","Harbin University of Commerce, Harbin, Heilongjiang, 150006, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harbin University of Commerce , Harbin , Heilongjiang , 150006 , China","institution_ids":["https://openalex.org/I41208885"]},{"raw_affiliation_string":"Harbin University of Commerce, Harbin, Heilongjiang, 150006, China","institution_ids":["https://openalex.org/I41208885"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5108575570"],"corresponding_institution_ids":["https://openalex.org/I41208885"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.30977526,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"4","first_page":"p365","last_page":"p365"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10019","display_name":"Corporate Finance and Governance","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10019","display_name":"Corporate Finance and Governance","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11043","display_name":"Merger and Competition Analysis","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12123","display_name":"Financial Analysis and Corporate Governance","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1402","display_name":"Accounting"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/contract-research-organizations","display_name":"contract research organizations","score":0.6940000057220459},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.6140000224113464},{"id":"https://openalex.org/keywords/biotechnology-companies","display_name":"biotechnology companies","score":0.8880000114440918},{"id":"https://openalex.org/keywords/vertical-integration","display_name":"vertical integration","score":0.8140000104904175},{"id":"https://openalex.org/keywords/acquisition-motives","display_name":"acquisition motives","score":0.6850000023841858},{"id":"https://openalex.org/keywords/post-merger-performance","display_name":"post-merger performance","score":0.7289999723434448},{"id":"https://openalex.org/keywords/chinese-pharmaceutical-companies","display_name":"Chinese pharmaceutical companies","score":0.6779999732971191}],"concepts":[{"id":"https://openalex.org/C548217281","wikidata":"https://www.wikidata.org/wiki/Q731112","display_name":"Mergers and acquisitions","level":2,"score":0.788537859916687},{"id":"https://openalex.org/C158016649","wikidata":"https://www.wikidata.org/wiki/Q161726","display_name":"Multinational corporation","level":2,"score":0.7628895044326782},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.7188745141029358},{"id":"https://openalex.org/C191935318","wikidata":"https://www.wikidata.org/wiki/Q148","display_name":"China","level":2,"score":0.5868239402770996},{"id":"https://openalex.org/C91306197","wikidata":"https://www.wikidata.org/wiki/Q45767","display_name":"Competition (biology)","level":2,"score":0.5863204598426819},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5556433796882629},{"id":"https://openalex.org/C40700","wikidata":"https://www.wikidata.org/wiki/Q1411783","display_name":"Industrial organization","level":1,"score":0.5108923316001892},{"id":"https://openalex.org/C58546491","wikidata":"https://www.wikidata.org/wiki/Q1150207","display_name":"Competitive advantage","level":2,"score":0.4287121593952179},{"id":"https://openalex.org/C2776299755","wikidata":"https://www.wikidata.org/wiki/Q432449","display_name":"Carry (investment)","level":2,"score":0.42495888471603394},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.33445483446121216},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.2234501838684082},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.2013058066368103},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.22158/jepf.v10n4p365","doi":"https://doi.org/10.22158/jepf.v10n4p365","is_oa":true,"landing_page_url":"https://doi.org/10.22158/jepf.v10n4p365","pdf_url":"http://www.scholink.org/ojs/index.php/jepf/article/download/55498/11153","source":{"id":"https://openalex.org/S4210220026","display_name":"Journal of Economics and Public Finance","issn_l":"2377-1038","issn":["2377-1038","2377-1046"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Economics and Public Finance","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.22158/jepf.v10n4p365","doi":"https://doi.org/10.22158/jepf.v10n4p365","is_oa":true,"landing_page_url":"https://doi.org/10.22158/jepf.v10n4p365","pdf_url":"http://www.scholink.org/ojs/index.php/jepf/article/download/55498/11153","source":{"id":"https://openalex.org/S4210220026","display_name":"Journal of Economics and Public Finance","issn_l":"2377-1038","issn":["2377-1038","2377-1046"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Economics and Public Finance","raw_type":"journal-article"},"sustainable_development_goals":[],"sustainable_development_goals_aurora":[{"score":0.6399999856948853,"display_name":"Industry, innovation and infrastructure","id":"https://metadata.un.org/sdg/9"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405259072.pdf","grobid_xml":"https://content.openalex.org/works/W4405259072.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W4380634344","https://openalex.org/W4390047180","https://openalex.org/W4390680604","https://openalex.org/W4404565595","https://openalex.org/W4404811943"],"related_works":["https://openalex.org/W560905060","https://openalex.org/W3146347817","https://openalex.org/W4248941464","https://openalex.org/W2348308266","https://openalex.org/W2150379823","https://openalex.org/W3176377222","https://openalex.org/W3107667671","https://openalex.org/W2371459757","https://openalex.org/W2097827202","https://openalex.org/W4386292311"],"abstract_inverted_index":{"With":[0],"the":[1,4,8,11,23,38,41,50,55,70,99,103,107,115,118,123,146,152],"development":[2,147],"of":[3,49,54,92,109,117,148,154],"international":[5,12,56],"CRO":[6,13,43,57,73],"industry,":[7],"competition":[9],"in":[10,22,85,169],"industry":[14,44,58],"has":[15,45],"become":[16],"more":[17,19],"and":[18,27,29,52,61,64,81,97,113,135,142],"intense,":[20],"especially":[21],"past":[24],"decade,":[25],"mergers":[26,134],"acquisitions":[28,136],"integration":[30,53],"between":[31],"multinational":[32],"pharmaceutical":[33,167],"companies":[34,168],"are":[35],"common.":[36],"At":[37],"same":[39],"time,":[40],"domestic":[42,72],"also":[46,78,161],"taken":[47],"advantage":[48],"M&A":[51,158],"to":[59],"develop":[60],"grow":[62],"rapidly":[63],"improve":[65],"its":[66],"competitive":[67],"ability.":[68],"As":[69],"largest":[71],"company,":[74],"WuXi":[75,110,149,155],"AppTec":[76],"is":[77],"continuously":[79],"acquiring":[80],"integrating":[82],"excellent":[83],"enterprises":[84],"various":[86],"industries,":[87],"gradually":[88],"forming":[89],"a":[90,140],"pattern":[91],"vertical":[93],"integration.":[94],"By":[95],"collecting":[96],"collating":[98],"financial":[100],"data":[101],"during":[102],"acquisition":[104],"cases,":[105],"analysing":[106,114],"motivation":[108],"AppTec's":[111,156],"M&A,":[112],"performance":[116],"company":[119],"by":[120],"combining":[121],"with":[122],"event":[124],"study":[125],"method,":[126],"it":[127],"can":[128,137,160],"be":[129],"seen":[130],"that":[131],"these":[132],"consecutive":[133],"indeed":[138],"bring":[139],"positive":[141],"active":[143],"impact":[144],"on":[145],"AppTec.":[150],"Further,":[151],"success":[153],"successive":[157,175],"events":[159],"provide":[162],"reference":[163],"experience":[164],"for":[165],"other":[166],"China":[170],"when":[171],"they":[172],"carry":[173],"out":[174],"M&A.":[176]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}